ENTITY
Indegene

Indegene (INDGN IN)

42
Analysis
Health Care • India
Indegene is an Indian company that offers digitally-led commercialization services to biopharmaceutical and healthcare enterprises globally. It provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics. The company is headquartered in Bangalore, India, and was founded in 1998.
more
bearish•Sagility
•11 Nov 2024 13:14

Sagility India IPO Trading - Lackluster Demand

Sagility India (2058883D IN) raised US$250m in its India IPO. We have looked at the company’s past performance and valuations in our earlier notes....

Logo
715 Views
Share
bearish•Sagility
•05 Nov 2024 16:12

Sagility India IPO - Hard to Ignore the Growing Concentration Risk

Sagility India (2058883D IN) is looking to raise US$250m in its India IPO. In this note, we look at the RHP updates, undertake a peer comparison,...

Logo
738 Views
Share
bullish•Swiggy
•04 Nov 2024 08:44

ECM Weekly (4th Nov 2024) - Swiggy, Waaree, Afcons, TS Lines, Zeekr, Hyundai Marine, Indegene, TBO

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
577 Views
Share
bearish•Indegene
•31 Oct 2024 07:00

Indegene Lockup Expiry - US$1bn+ Lockup Release, Some Could Look to Book 3x Gain

Indegene Limited (1864095D IN) was listed in India on 13th May 2024 after raising US$221m. Its six-month lockup will expire on 5th Nov 2024.

Logo
512 Views
Share
bullish•Sagility
•17 Sep 2024 10:00

Sagility India Pre-IPO - Healthcare-Tech Exposure Although Alarming Concentration Risks to Watch For

Sagility India (2058883D IN) is looking to raise US$500m in its upcoming India IPO. Sagility India is a pure-play healthcare focused solutions and...

Logo
854 Views
Share
x